I. Introduction
Anxiety disorders affect 275 million individuals worldwide. On the subclinical level, heightened anxiety is becoming increasingly prevalent in light of growing uncertainty over the global health and economical situation in 2020-2021. In recent years, an enormous effort has been devoted to understanding the neurobiology of anxiety disorders, combining animal work with human neuroimaging studies in healthy and clinical populations.